Decline of influenza-specific CD8+ T cell repertoire in healthy geriatric donors

Immunity and Ageing

Volumn 8, Issue , 2011, Pages

  Lee, Jessica B ^a   Oelke, Mathias ^a   Ramachandra, Lakshmi ^b,c   Canaday, David H ^d   Schneck, Jonathan P ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d Education and Clinical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HLA A2 ANTIGEN;

ADULT; AGED; ANTIGEN PRESENTING CELL; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DONOR; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; GERIATRICS; HUMAN; IMMUNE RESPONSE; INFLUENZA; MALE; NORMAL HUMAN; PRIORITY JOURNAL; STIMULATION;

EID: 80051605256     PISSN: None     EISSN: 17424933     Source Type: Journal    
DOI: 10.1186/1742-4933-8-6     Document Type: Article

References (41)

1. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, Fukuda K. Mortality associated with influenza and respiratory syncytial virus in the United States. Jama 2003, 289:179-186. 10.1001/jama.289.2.179, 12517228.
2. Thompson WW, Weintraub E, Dhankhar P, Cheng PY, Brammer L, Meltzer MI, Bresee JS, Shay DK. Estimates of US influenza-associated deaths made using four different methods. Influenza and other respiratory viruses 2009, 3:37-49. 10.1111/j.1750-2659.2009.00073.x, 19453440.
3. Webster RG. Immunity to influenza in the elderly. Vaccine 2000, 18:1686-1689. 10.1016/S0264-410X(99)00507-1, 10689149.
4. Linton PJ, Dorshkind K. Age-related changes in lymphocyte development and function. Nature immunology 2004, 5:133-139.
5. Grubeck-Loebenstein B, Wick G. The aging of the immune system. Advances in immunology 2002, 80:243-284.
6. Miller RA. Aging and immune function. International review of cytology 1991, 124:187-215.
7. Miller RA. The aging immune system: primer and prospectus. Science (New York, NY) 1996, 273:70-74.
8. Waldman RH, Mann JJ, Small PA. Immunization against influenza. Prevention of illness in man by aerosolized inactivated vaccine. Jama 1969, 207:520-524. 10.1001/jama.207.3.520, 5818213.
9. La Gruta NL, Kedzierska K, Stambas J, Doherty PC. A question of self-preservation: immunopathology in influenza virus infection. Immunol Cell Biol 2007, 85:85-92. 10.1038/sj.icb.7100026, 17213831.
10. Doherty PC, Topham DJ, Tripp RA, Cardin RD, Brooks JW, Stevenson PG. Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections. Immunological reviews 1997, 159:105-117. 10.1111/j.1600-065X.1997.tb01010.x, 9416506.
11. Naumov YN, Naumova EN, Clute SC, Watkin LB, Kota K, Gorski J, Selin LK. Complex T cell memory repertoires participate in recall responses at extremes of antigenic load. J Immunol 2006, 177:2006-2014.
12. Lukacher AE, Braciale VL, Braciale TJ. In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific. J Exp Med 1984, 160:814-826. 10.1084/jem.160.3.814, 2187390, 6206190.
13. Mackenzie CD, Taylor PM, Askonas BA. Rapid recovery of lung histology correlates with clearance of influenza virus by specific CD8+ cytotoxic T cells. Immunology 1989, 67:375-381. 1385356, 2788128.
14. Kuwano K, Scott M, Young JF, Ennis FA. HA2 subunit of influenza A H1 and H2 subtype viruses induces a protective cross-reactive cytotoxic T lymphocyte response. J Immunol 1988, 140:1264-1268.
15. Kuwano K, Braciale TJ, Ennis FA. Cytotoxic T lymphocytes recognize a cross-reactive epitope on the transmembrane region of influenza H1 and H2 hemagglutinins. Viral Immunol 1989, 2:163-173. 10.1089/vim.1989.2.163, 2483503.
16. Gotch F, McMichael A, Smith G, Moss B. Identification of viral molecules recognized by influenza-specific human cytotoxic T lymphocytes. J Exp Med 1987, 165:408-416. 10.1084/jem.165.2.408, 2188513, 3029268.
17. Bednarek MA, Sauma SY, Gammon MC, Porter G, Tamhankar S, Williamson AR, Zweerink HJ. The minimum peptide epitope from the influenza virus matrix protein. Extra and intracellular loading of HLA-A2. J Immunol 1991, 147:4047-4053.
18. Morrison J, Elvin J, Latron F, Gotch F, Moots R, Strominger JL, McMichael A. Identification of the nonamer peptide from influenza A matrix protein and the role of pockets of HLA-A2 in its recognition by cytotoxic T lymphocytes. Eur J Immunol 1992, 22:903-907. 10.1002/eji.1830220404, 1372560.
19. Jameson J, Cruz J, Ennis FA. Human cytotoxic T-lymphocyte repertoire to influenza A viruses. J Virol 1998, 72:8682-8689. 110281, 9765409.
20. Assarsson E, Bui HH, Sidney J, Zhang Q, Glenn J, Oseroff C, Mbawuike IN, Alexander J, Newman MJ, Grey H, Sette A. Immunomic analysis of the repertoire of T-cell specificities for influenza A virus in humans. J Virol 2008, 82:12241-12251. 10.1128/JVI.01563-08, 2593359, 18842709.
21. Gianfrani C, Oseroff C, Sidney J, Chesnut RW, Sette A. Human memory CTL response specific for influenza A virus is broad and multispecific. Hum Immunol 2000, 61:438-452. 10.1016/S0198-8859(00)00105-1, 10773346.
22. Sercarz EE, Lehmann PV, Ametani A, Benichou G, Miller A, Moudgil K. Dominance and crypticity of T cell antigenic determinants. Annual review of immunology 1993, 11:729-766. 10.1146/annurev.iy.11.040193.003501, 7682817.
23. Oelke M, Maus MV, Didiano D, June CH, Mackensen A, Schneck JP. Ex vivo induction and expansion of antigen-specific cytotoxic T cells by HLA-Ig-coated artificial antigen-presenting cells. Nat Med 2003, 9:619-624. 10.1038/nm869, 12704385.
24. Lehner PJ, Wang EC, Moss PA, Williams S, Platt K, Friedman SM, Bell JI, Borysiewicz LK. Human HLA-A0201-restricted cytotoxic T lymphocyte recognition of influenza A is dominated by T cells bearing the V beta 17 gene segment. J Exp Med 1995, 181:79-91. 10.1084/jem.181.1.79, 2191841, 7807026.
25. Moss PA, Moots RJ, Rosenberg WM, Rowland-Jones SJ, Bodmer HC, McMichael AJ, Bell JI. Extensive conservation of alpha and beta chains of the human T-cell antigen receptor recognizing HLA-A2 and influenza A matrix peptide. Proc Natl Acad Sci USA 1991, 88:8987-8990. 10.1073/pnas.88.20.8987, 52636, 1833769.
26. Deng Y, Jing Y, Campbell AE, Gravenstein S. Age-related impaired type 1 T cell responses to influenza: reduced activation ex vivo, decreased expansion in CTL culture in vitro, and blunted response to influenza vaccination in vivo in the elderly. J Immunol 2004, 172:3437-3446.
27. Fagnoni FF, Vescovini R, Passeri G, Bologna G, Pedrazzoni M, Lavagetto G, Casti A, Franceschi C, Passeri M, Sansoni P. Shortage of circulating naive CD8(+) T cells provides new insights on immunodeficiency in aging. Blood 2000, 95:2860-2868.
28. Almanzar G, Herndler-Brandstetter D, Chaparro SV, Jenewein B, Keller M, Grubeck-Loebenstein B. Immunodominant peptides from conserved influenza proteins--a tool for more efficient vaccination in the elderly?. Wien Med Wochenschr 2007, 157:116-121. 10.1007/s10354-007-0393-y, 17427008.
29. Khan N, Shariff N, Cobbold M, Bruton R, Ainsworth JA, Sinclair AJ, Nayak L, Moss PA. Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J Immunol 2002, 169:1984-1992.
30. Posnett DN, Sinha R, Kabak S, Russo C. Clonal populations of T cells in normal elderly humans: the T cell equivalent to "benign monoclonal gammapathy". The Journal of experimental medicine 1994, 179:609-618. 10.1084/jem.179.2.609, 2191374, 8294871.
31. Kim JH, Skountzou I, Compans R, Jacob J. Original antigenic sin responses to influenza viruses. J Immunol 2009, 183:3294-3301. 10.4049/jimmunol.0900398, 19648276.
32. Davenport FM, Hennessy AV, Francis T. Epidemiologic and immunologic significance of age distribution of antibody to antigenic variants of influenza virus. The Journal of experimental medicine 1953, 98:641-656. 10.1084/jem.98.6.641, 2136340, 13109114.
33. Yager EJ, Ahmed M, Lanzer K, Randall TD, Woodland DL, Blackman MA. Age-associated decline in T cell repertoire diversity leads to holes in the repertoire and impaired immunity to influenza virus. J Exp Med 2008, 205:711-723. 10.1084/jem.20071140, 2275391, 18332179.
34. Welsh RM, Selin LK. No one is naive: the significance of heterologous T-cell immunity. Nat Rev Immunol 2002, 2:417-426.
35. Durai M, Krueger C, Ye Z, Cheng L, Mackensen A, Oelke M, Schneck JP. In vivo functional efficacy of tumor-specific T cells expanded using HLA-Ig based artificial antigen presenting cells (aAPC). Cancer Immunol Immunother 2009, 58:209-220. 10.1007/s00262-008-0542-1, 2680120, 18563409.
36. Boon AC, Fringuelli E, Graus YM, Fouchier RA, Sintnicolaas K, Iorio AM, Rimmelzwaan GF, Osterhaus AD. Influenza A virus specific T cell immunity in humans during aging. Virology 2002, 299:100-108. 10.1006/viro.2002.1491, 12167345.
37. McElhaney JE, Xie D, Hager WD, Barry MB, Wang Y, Kleppinger A, Ewen C, Kane KP, Bleackley RC. T cell responses are better correlates of vaccine protection in the elderly. J Immunol 2006, 176:6333-6339.
38. Oelke M, Moehrle U, Chen JL, Behringer D, Cerundolo V, Lindemann A, Mackensen A. Generation and purification of CD8+ melan-A-specific cytotoxic T lymphocytes for adoptive transfer in tumor immunotherapy. Clin Cancer Res 2000, 6:1997-2005.
39. Slansky JE, Rattis FM, Boyd LF, Fahmy T, Jaffee EM, Schneck JP, Margulies DH, Pardoll DM. Enhanced antigen-specific antitumor immunity with altered peptide ligands that stabilize the MHC-peptide-TCR complex. Immunity 2000, 13:529-538. 10.1016/S1074-7613(00)00052-2, 11070171.
40. Kasprowicz V, Ward SM, Turner A, Grammatikos A, Nolan BE, Lewis-Ximenez L, Sharp C, Woodruff J, Fleming VM, Sims S, et al. Defining the directionality and quality of influenza virus-specific CD8+ T cell cross-reactivity in individuals infected with hepatitis C virus. J Clin Invest 2008, 118:1143-1153. 2214846, 18246203.
41. Daly K, Nguyen P, Woodland DL, Blackman MA. Immunodominance of major histocompatibility complex class I-restricted influenza virus epitopes can be influenced by the T-cell receptor repertoire. J Virol 1995, 69:7416-7422. 189678, 7494246.